These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 3005181
21. High-performance liquid chromatographic determination of enalapril in human plasma by enzyme kinetic analytical method. Thongnopnua P, Poeaknapo C. J Pharm Biomed Anal; 2005 Apr 01; 37(4):763-9. PubMed ID: 15797799 [Abstract] [Full Text] [Related]
22. High serum enalaprilat in chronic renal failure. Elung-Jensen T, Heisterberg J, Kamper AL, Sonne J, Strandgaard S, Larsen NE. J Renin Angiotensin Aldosterone Syst; 2001 Dec 01; 2(4):240-5. PubMed ID: 11881130 [Abstract] [Full Text] [Related]
23. Evaluation of angiotensin converting enzyme (ACE) in the pharmacokinetics and pharmacodynamics of ACE inhibitors. Johnston CI, Jackson B, Cubela R, Larmour I, Arnolda L. J Cardiovasc Pharmacol; 1986 Dec 01; 8 Suppl 1():S9-14. PubMed ID: 2422495 [Abstract] [Full Text] [Related]
24. Pharmacokinetics and pharmacodynamics of a nitric oxide-releasing derivative of enalapril in male beagles. Okuyama CE, Mendes GD, Faro R, Rezende VM, Lagos RM, Astigarraga RE, Antunes E, De Nucci G. Clin Exp Pharmacol Physiol; 2007 Apr 01; 34(4):290-5. PubMed ID: 17324140 [Abstract] [Full Text] [Related]
25. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme. Grinshtein SV, Binevski PV, Gomazkov OA, Pozdnev VF, Nikolskaya II, Kost OA. Biochemistry (Mosc); 1999 Aug 01; 64(8):938-44. PubMed ID: 10498812 [Abstract] [Full Text] [Related]
26. Kinetics and dynamics of enalapril in patients with liver cirrhosis. Ohnishi A, Tsuboi Y, Ishizaki T, Kubota K, Ohno T, Yoshida H, Kanezaki A, Tanaka T. Clin Pharmacol Ther; 1989 Jun 01; 45(6):657-65. PubMed ID: 2543535 [Abstract] [Full Text] [Related]
28. Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors. Bourgault C, Elstein E, Le Lorier J, Suissa S. CMAJ; 1999 Aug 10; 161(3):255-60. PubMed ID: 10463046 [Abstract] [Full Text] [Related]
29. Kinetic and metabolic aspects of enalapril action. Lant AF, McNabb RW, Noormohamed FH. J Hypertens Suppl; 1984 Dec 10; 2(2):S37-42. PubMed ID: 6100875 [Abstract] [Full Text] [Related]
31. Pharmacokinetics of lisinopril, enalapril and enalaprilat in renal failure: effects of haemodialysis. Kelly JG, Doyle GD, Carmody M, Glover DR, Cooper WD. Br J Clin Pharmacol; 1988 Dec 10; 26(6):781-6. PubMed ID: 2853960 [Abstract] [Full Text] [Related]
38. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned? Erman A, Boner G, van Dijk DJ. J Renin Angiotensin Aldosterone Syst; 2000 Dec 10; 1(4):365-8. PubMed ID: 11967825 [Abstract] [Full Text] [Related]